Key facts
- INTRACOASTAL CAPITAL, LLC filed SCHEDULE 13G for Adial Pharmaceuticals, Inc. Common stock, par value $0.001 per share (ADIL).
- Disclosed ownership: 2.8%.
- Date of event: 17 Jun 2025.
INTRACOASTAL CAPITAL, LLC - 17 Jun 2025 SCHEDULE 13G Report for Adial Pharmaceuticals, Inc. Common stock, par value $0.001 per share (ADIL)
- Filing Manager
- INTRACOASTAL CAPITAL, LLC
- Reporting Manager
- Mitchell P. Kopin
- Symbol
- ADIL
- Shares outstanding
- 15,938,643 shares
- Disclosed Ownership
- 446,282 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Jun 2025, 06:03:26 UTC
- Date of event
- 17 Jun 2025
- SEC
- View on sec.gov
Key filing fact
INTRACOASTAL CAPITAL, LLC disclosed 2.8% ownership in Adial Pharmaceuticals, Inc. Common stock, par value $0.001 per share (ADIL) on 17 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Jun 2025, 06:03.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mitchell P. Kopin | 2.8% | 446,282 | 0 | 446,282 | /s/ Mitchell P. Kopin | Mitchell P. Kopin | |
| Daniel B. Asher | 2.8% | 446,282 | 0 | 446,282 | /s/ Daniel B. Asher | Daniel B. Asher | |
| Intracoastal Capital LLC | 2.8% | 446,282 | 0 | 446,282 | /s/ Mitchell P. Kopin | Mitchell P. Kopin, Manager |
CIK / CUSIP context first